Literature DB >> 6321409

Oat cell carcinoma of esophagus: a report of six British patients with a review of the literature.

M A Doherty, M McIntyre, S J Arnott.   

Abstract

This paper presents 6 British patients with a diagnosis of oat cell carcinoma of the esophagus. Sixty-six patients have previously been reported in the literature, the majority (30) being British. Approximately two-thirds of these tumors have been reported as pure oat cell carcinoma of the esophagus. Four other histological patterns have been described: oat cell carcinoma with squamous carcinoma in situ; oat cell carcinoma with squamous carcinoma; oat cell carcinoma with adenocarcinoma; and oat cell carcinoma with carcinoid differentiation. A preponderance of males has also been noted, although this series shows a 2:1 female:male ratio. The tumor arises most commonly in the mid or lower esophagus. The cell of origin of these tumors in considered to be the Kulchitsky or APUD cell of neuroectodermal derivation. They may show neurosecretory granules on electron microscopy. Polypeptides have been identified within the tumor cells. One previous report describes a patient with primary oat cell carcinoma of the esophagus and hypercalcemia. A patient with the syndrome of inappropriate anti-diuretic hormone secretion is described in this paper. Survival is poor following radiotherapy, with a median survival of 3 months in this series. On reviewing the records of the Radiation Oncology Unit in Edinburgh, no patient with oat cell carcinoma of the esophagus was reported before 1972. This suggests that awareness of this tumor is increasing and, although rare, its incidence is greater than previously reported.

Entities:  

Mesh:

Year:  1984        PMID: 6321409     DOI: 10.1016/0360-3016(84)90421-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

Review 1.  Extrapulmonary small cell carcinoma.

Authors:  J A Ledermann
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

Review 2.  A case of an undifferentiated small cell carcinoma of the esophagus with a primary abdominal mass.

Authors:  C Inada; A Toyonaga; S Itano; K Kuwano; Y Sano; R Maekawa; T Kawahara; O Tsuruta; E Sasaki; K Tanikawa
Journal:  Gastroenterol Jpn       Date:  1992-04

3.  Small-cell carcinoma of the esophagus. Treatment by endoscopy.

Authors:  G Di Felice; M Dal Fante; P Spinelli
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

Review 4.  Treatment of oesophageal small cell carcinoma by combined chemotherapy and surgical resection: report of two cases and review of published cases.

Authors:  S J Walker; A Steel; M H Cullen; H R Matthews
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

Review 5.  Small cell carcinoma of the oesophagus: report of three cases and review of published cases.

Authors:  D M Eccles; S G Allan; C T Sang; M A Cornbleet
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

6.  Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies.

Authors:  Tadashi Terada; Hirotoshi Maruo
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

7.  Primary oat cell carcinoma of the oesophagus.

Authors:  S Sabanathan; G P Graham; F D Salama
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

Review 8.  Small cell carcinoma of the esophagus. Report of three cases and review of the literature.

Authors:  B M Attar; H Levendoglu; H Rhee
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

Review 9.  Primary small cell carcinoma of the esophagus: case presentation and review of the literature.

Authors:  L D Mulder; G A Gardiner; D A Weeks
Journal:  Gastrointest Radiol       Date:  1991

10.  [A rare case of a neuroendocrine carcinoma of the esophagus. Intermediate between a well-differentiated neuroendocrine carcinoma and a low-differentiated neuroendocrine carcinoma].

Authors:  T Gumprich; G Johnen; T Hummel; M Jaworska; I Schmitz; K-M Müller
Journal:  Pathologe       Date:  2004-05       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.